These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18225756)

  • 1. Combined effect of bis-beta-chloroethylamine estrogen derivatives and doxorubicin on proliferation of sensitive and resistant MCF-7 cells.
    Mayatskaya EE; Shimanovskii NL; Banin VV; Fedotcheva TA; Semeikin AV; Rzheznikov VM
    Bull Exp Biol Med; 2007 Mar; 143(3):334-6. PubMed ID: 18225756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
    Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
    Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined action of doxorubicin and gestagens on doxorubicin-sensitive and doxorubicin-resistant MCF-7 cells.
    Sergeev PV; Semeikin AV; Fedotcheva TA; Samoilikov RV; Kamernitskii AV; Levina IS; Rzheznikov VM; Grinenko GS; Korystov YN; Ermakova NV; Shaposhnikova VV; Shimanovskii NL
    Bull Exp Biol Med; 2003 Nov; 136(5):460-3. PubMed ID: 14968160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin.
    Płonka-Czerw J; Żyrek L; Latocha M
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor and antiproliferative action of the steroidal cytostatic antiestrogen cytestrol acetate on hormone-dependent tumor models].
    Smirnova zS; Rzheznikov VM; Tolkachev VN; Borisova LM; Kiseleva MP; Semeĭkin AV; Fedotcheva TA; Shirokikh KE; Banin VV; Shimanovskiĭ NL
    Eksp Klin Farmakol; 2014; 77(10):31-5. PubMed ID: 25518525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance.
    Skildum A; Dornfeld K; Wallace K
    Breast Cancer Res Treat; 2011 Oct; 129(3):785-97. PubMed ID: 21128112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics.
    Chekhun VF; Borikun TV; Lukianova NY
    Exp Oncol; 2016 Mar; 38(1):26-30. PubMed ID: 27031715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer.
    Maynadier M; Basile I; Gallud A; Gary-Bobo M; Garcia M
    Oncol Rep; 2016 Aug; 36(2):1127-34. PubMed ID: 27373750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of bis-beta-chloroethylamine derivatives of synthetic estrogens to proteins: dependence on the chemical structure.
    Mayatskaya EE; Semeikin AV; Rzheznikov VM; Shimanovskii NL
    Bull Exp Biol Med; 2002 Dec; 134(6):544-7. PubMed ID: 12660833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
    Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
    Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
    Bouker KB; Skaar TC; Fernandez DR; O'Brien KA; Riggins RB; Cao D; Clarke R
    Cancer Res; 2004 Jun; 64(11):4030-9. PubMed ID: 15173018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7.
    Trebunova M; Laputkova G; Slaba E; Lacjakova K; Verebova A
    Anticancer Res; 2012 Jul; 32(7):2849-54. PubMed ID: 22753747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
    Juncker-Jensen A; Lykkesfeldt AE; Worm J; Ralfkiaer U; Espelund U; Jepsen JS
    Growth Horm IGF Res; 2006 Aug; 16(4):224-39. PubMed ID: 16893667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
    Pennanen PT; Sarvilinna NS; Ylikomi TJ
    Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6alpha-Methyl-16alpha,17alpha-cyclohexane progesterone and progesterone inhibit growth of doxorubicin-sensitive MCF-7 and HeLa tumor cells.
    Shimanovskii NL; Semeikin AV; Fedotcheva TA; Fedosov AV; Kamernitskii AV; Levina IS
    Bull Exp Biol Med; 2002 Oct; 134(4):385-8. PubMed ID: 12533767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668.
    Fog CK; Christensen IJ; Lykkesfeldt AE
    Breast Cancer Res Treat; 2005 May; 91(2):133-44. PubMed ID: 15868441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.